Cargando…
The Next Paradigm Shift in the Management of Clear Cell Renal Cancer: Radiogenomics—Definition, Current Advances, and Future Directions
SIMPLE SUMMARY: Radiogenomics is the science of studying imaging–pathology associations on a genomic level. With the potential for improved non-invasive characterization of tumors to predict survival; metastasis; and/or treatment response, it is important for clinicians to have a basic appreciation...
Autores principales: | Gopal, Nikhil, Yazdian Anari, Pouria, Turkbey, Evrim, Jones, Elizabeth C., Malayeri, Ashkan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833879/ https://www.ncbi.nlm.nih.gov/pubmed/35159060 http://dx.doi.org/10.3390/cancers14030793 |
Ejemplares similares
-
CT radiomics for differentiating fat poor angiomyolipoma from clear cell renal cell carcinoma: Systematic review and meta-analysis
por: Dehghani Firouzabadi, Fatemeh, et al.
Publicado: (2023) -
Automatic segmentation of clear cell renal cell tumors, kidney, and cysts in patients with von Hippel-Lindau syndrome using U-net architecture on magnetic resonance images
por: Anari, Pouria Yazdian, et al.
Publicado: (2023) -
Preoperative Renal Parenchyma Volume as a Predictor of Kidney Function Following Nephrectomy of Complex Renal Masses
por: Antony, Maria B., et al.
Publicado: (2023) -
Radiogenomics in Clear Cell Renal Cell Carcinoma: A Review of the Current Status and Future Directions
por: Khaleel, Sari, et al.
Publicado: (2022) -
Radiogenomics study to predict the nuclear grade of renal clear cell carcinoma()
por: He, Xuan-ming, et al.
Publicado: (2023)